Reviews Entecavir


No reviews yet.

Baraclude Drug Description
BARACLUDE
(entecavir) Tablets
BARACLUDE
(entecavir) Oral Solution

WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED
WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients
who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic
function should be monitored closely with both clinical and laboratory follow-up
for at least several months in patients who discontinue anti-hepatitis B therapy.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS AND PRECAUTIONS].
Limited clinical experience suggests there is a potential for the development
of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase
inhibitors if BARACLUDE (entecavir) is used to treat chronic hepatitis B virus
(HBV) infection in patients with HIV infection that is not being treated.
Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients
who are not also receiving highly active antiretroviral therapy (HAART) [see
WARNINGS AND PRECAUTIONS].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination with antiretrovirals [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of entecavir (Baraclude)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling in your arms and legs;
...
Read All Potential Side Effects for Baraclude »




BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue
with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
monohydrate. Its molecular formula is C12H15N5O3•H2O,
which corresponds to a molecular weight of 295.3. Entecavir has the following
structural formula:








Entecavir is a white to off-white powder. It is slightly soluble in water (2.4 mg/mL), and the pH of the saturated solution in water is 7.9 at 25° ± 0.5° C.
BARACLUDE film-coated tablets are available for oral administration in strengths of 0.5 mg and 1 mg of entecavir. BARACLUDE 0.5-mg and 1-mg film-coated tablets contain the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate. The tablet coating contains titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80 (0.5-mg tablet only), and iron oxide red (1-mg tablet only). BARACLUDE Oral Solution is available for oral administration as a ready-to-use solution containing 0.05 mg of entecavir per milliliter. BARACLUDE Oral Solution contains the following inactive ingredients: maltitol, sodium citrate, citric acid, methylparaben, propylparaben, and orange flavor.
Last reviewed on RxList: 4/14/2009




Baraclude Drug Description
BARACLUDE
(entecavir) Tablets
BARACLUDE
(entecavir) Oral Solution

WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED
WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients
who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic
function should be monitored closely with both clinical and laboratory follow-up
for at least several months in patients who discontinue anti-hepatitis B therapy.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS AND PRECAUTIONS].
Limited clinical experience suggests there is a potential for the development
of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase
inhibitors if BARACLUDE (entecavir) is used to treat chronic hepatitis B virus
(HBV) infection in patients with HIV infection that is not being treated.
Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients
who are not also receiving highly active antiretroviral therapy (HAART) [see
WARNINGS AND PRECAUTIONS].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination with antiretrovirals [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of entecavir (Baraclude)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling in your arms and legs;
...
Read All Potential Side Effects for Baraclude »




BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue
with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
monohydrate. Its molecular formula is C12H15N5O3•H2O,
which corresponds to a molecular weight of 295.3. Entecavir has the following
structural formula:








Entecavir is a white to off-white powder. It is slightly soluble in water (2.4 mg/mL), and the pH of the saturated solution in water is 7.9 at 25° ± 0.5° C.
BARACLUDE film-coated tablets are available for oral administration in strengths of 0.5 mg and 1 mg of entecavir. BARACLUDE 0.5-mg and 1-mg film-coated tablets contain the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate. The tablet coating contains titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80 (0.5-mg tablet only), and iron oxide red (1-mg tablet only). BARACLUDE Oral Solution is available for oral administration as a ready-to-use solution containing 0.05 mg of entecavir per milliliter. BARACLUDE Oral Solution contains the following inactive ingredients: maltitol, sodium citrate, citric acid, methylparaben, propylparaben, and orange flavor.
Last reviewed on RxList: 4/14/2009




Baraclude Drug Description
BARACLUDE
(entecavir) Tablets
BARACLUDE
(entecavir) Oral Solution

WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED
WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients
who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic
function should be monitored closely with both clinical and laboratory follow-up
for at least several months in patients who discontinue anti-hepatitis B therapy.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS AND PRECAUTIONS].
Limited clinical experience suggests there is a potential for the development
of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase
inhibitors if BARACLUDE (entecavir) is used to treat chronic hepatitis B virus
(HBV) infection in patients with HIV infection that is not being treated.
Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients
who are not also receiving highly active antiretroviral therapy (HAART) [see
WARNINGS AND PRECAUTIONS].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination with antiretrovirals [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of entecavir (Baraclude)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling in your arms and legs;
...
Read All Potential Side Effects for Baraclude »




BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue
with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
monohydrate. Its molecular formula is C12H15N5O3•H2O,
which corresponds to a molecular weight of 295.3. Entecavir has the following
structural formula:








Entecavir is a white to off-white powder. It is slightly soluble in water (2.4 mg/mL), and the pH of the saturated solution in water is 7.9 at 25° ± 0.5° C.
BARACLUDE film-coated tablets are available for oral administration in strengths of 0.5 mg and 1 mg of entecavir. BARACLUDE 0.5-mg and 1-mg film-coated tablets contain the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate. The tablet coating contains titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80 (0.5-mg tablet only), and iron oxide red (1-mg tablet only). BARACLUDE Oral Solution is available for oral administration as a ready-to-use solution containing 0.05 mg of entecavir per milliliter. BARACLUDE Oral Solution contains the following inactive ingredients: maltitol, sodium citrate, citric acid, methylparaben, propylparaben, and orange flavor.
Last reviewed on RxList: 4/14/2009




Baraclude Drug Description
BARACLUDE
(entecavir) Tablets
BARACLUDE
(entecavir) Oral Solution

WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED
WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients
who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic
function should be monitored closely with both clinical and laboratory follow-up
for at least several months in patients who discontinue anti-hepatitis B therapy.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS AND PRECAUTIONS].
Limited clinical experience suggests there is a potential for the development
of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase
inhibitors if BARACLUDE (entecavir) is used to treat chronic hepatitis B virus
(HBV) infection in patients with HIV infection that is not being treated.
Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients
who are not also receiving highly active antiretroviral therapy (HAART) [see
WARNINGS AND PRECAUTIONS].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination with antiretrovirals [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of entecavir (Baraclude)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling in your arms and legs;
...
Read All Potential Side Effects for Baraclude »




BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue
with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
monohydrate. Its molecular formula is C12H15N5O3•H2O,
which corresponds to a molecular weight of 295.3. Entecavir has the following
structural formula:








Entecavir is a white to off-white powder. It is slightly soluble in water (2.4 mg/mL), and the pH of the saturated solution in water is 7.9 at 25° ± 0.5° C.
BARACLUDE film-coated tablets are available for oral administration in strengths of 0.5 mg and 1 mg of entecavir. BARACLUDE 0.5-mg and 1-mg film-coated tablets contain the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate. The tablet coating contains titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80 (0.5-mg tablet only), and iron oxide red (1-mg tablet only). BARACLUDE Oral Solution is available for oral administration as a ready-to-use solution containing 0.05 mg of entecavir per milliliter. BARACLUDE Oral Solution contains the following inactive ingredients: maltitol, sodium citrate, citric acid, methylparaben, propylparaben, and orange flavor.
Last reviewed on RxList: 4/14/2009




Baraclude Drug Description
BARACLUDE
(entecavir) Tablets
BARACLUDE
(entecavir) Oral Solution

WARNINGS: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED
WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
Severe acute exacerbations of hepatitis B have been reported in patients
who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic
function should be monitored closely with both clinical and laboratory follow-up
for at least several months in patients who discontinue anti-hepatitis B therapy.
If appropriate, initiation of anti-hepatitis B therapy may be warranted [see
WARNINGS AND PRECAUTIONS].
Limited clinical experience suggests there is a potential for the development
of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase
inhibitors if BARACLUDE (entecavir) is used to treat chronic hepatitis B virus
(HBV) infection in patients with HIV infection that is not being treated.
Therapy with BARACLUDE is not recommended for HIV/HBV co-infected patients
who are not also receiving highly active antiretroviral therapy (HAART) [see
WARNINGS AND PRECAUTIONS].
Lactic acidosis and severe hepatomegaly with steatosis, including fatal
cases, have been reported with the use of nucleoside analogues alone or in
combination with antiretrovirals [see WARNINGS AND PRECAUTIONS].

DRUG DESCRIPTION



What are the possible side effects of entecavir (Baraclude)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
This medication may cause lactic acidosis (a build-up of lactic acid in the body, which can be fatal). Lactic acidosis can start slowly and get worse over time. Get emergency medical help if you have even mild symptoms of lactic acidosis, such as:

muscle pain or weakness;
numb or cold feeling in your arms and legs;
...
Read All Potential Side Effects for Baraclude »




BARACLUDE® is the tradename for entecavir, a guanosine nucleoside analogue
with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,
monohydrate. Its molecular formula is C12H15N5O3•H2O,
which corresponds to a molecular weight of 295.3. Entecavir has the following
structural formula:








Entecavir is a white to off-white powder. It is slightly soluble in water (2.4 mg/mL), and the pH of the saturated solution in water is 7.9 at 25° ± 0.5° C.
BARACLUDE film-coated tablets are available for oral administration in strengths of 0.5 mg and 1 mg of entecavir. BARACLUDE 0.5-mg and 1-mg film-coated tablets contain the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, povidone, and magnesium stearate. The tablet coating contains titanium dioxide, hypromellose, polyethylene glycol 400, polysorbate 80 (0.5-mg tablet only), and iron oxide red (1-mg tablet only). BARACLUDE Oral Solution is available for oral administration as a ready-to-use solution containing 0.05 mg of entecavir per milliliter. BARACLUDE Oral Solution contains the following inactive ingredients: maltitol, sodium citrate, citric acid, methylparaben, propylparaben, and orange flavor.
Last reviewed on RxList: 4/14/2009





Other reviews about Entecavir on wordpress

Original Article - Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B
  by JOC
Source: N Engl J Med Mar 9, 2006 vol.354 N.10 p.1011-1020 Ching-Lung Lai, M.D., Daniel Shouval, M.D., Anna S. Lok, M.D., Ting-Tsung Chang, M.D., Hugo Cheinquer, M.D., Zachary Goodman, […]


Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients
  by JOC
April 30, 2007   Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents - October 10, 2006.   Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients   Previously, […]


Recycling unused prescription drugs
  by lniemi
Question: We have had some recent deaths in our family and have a quantity of unused prescription medication. Some of it is in sealed individual doses. It just […]


The cost-effectiveness of long-term antiviral therapy in the management of HBeAg-positive and HBeAg-negative chronic hepatitis B in Singapore
  by cnnews
Abstract Introduction Methods Results Discussion Conclusions References http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2156151#b29 Abstract The purpose of this study was the economic evaluation of short-duration treatments of chronic hepatitis B (CHB) and longer duration antiviral treatment for up to 5 years. Two […]


Treatment of chronic hepatitis B in HIV co-infected patients
  by cnnews
[Treatment of chronic hepatitis B in HIV co-infected patients] [Article in French] Massard J, Benhamou Y. Service d'Hepato-Gastroenterologie, Groupe hospitalier Pitie-Salpetriere, 47-83 boulevard de l'Hopital, 75651 Paris Cedex, France. Because of complex […]


Introducing HBV
  by cvang
Introduction: This specific presentation will revolve around Hepatitis B Virus, also known as HBV. HBV is a member of the Hepadnaviridae family. The name "hepa" comes from hepatotrophic and […]


How effective are the treatments?
  by cvang
Anti-viral Therapies The mechanisms of treatment and/or drug therapy differ slightly from drug to drug but the underlying bases of antiviral therapy are to reduce the amount of virus […]


Entecavir hydrate
  by likui0632
Entecavir hydrate Name: Entecavir hydrate Synonyms: 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate Molecular Structure:  Molecular Formula: C12H15N5O3.H2O Molecular Weight: 295.30 CAS Registry Number: 209216-23-9 Appearance: White to almost white crystalline powder Assay; not less than 99%  Entecavir is an oral prescription […]


Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition now available at ReportsandReports
  by reportsnreports
Dallas, TX: ReportsandReports announce it will carry  Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition Market Research […]


ReportsandReports - Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition
  by reportsnreports
Browse the complete Report Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competition Browse All Datamonitor Research Reports […]



Other reviews about Entecavir on web:

China pharmaceutical manufacturer of Entecavir, Entecavir intermediate, Lamivudine, Zidovudine, Nevirapine, Coenzyme Q10, Ritonavir, Lopinavir, Lafutidine (DMF), Entecavir ... Entecavir, Entecavir intermediate, Nevirapine, Ritonavir ...


Entecavir is an oral prescription antiviral medication used in the treatment of chronic hepatitis B. Entecavir is in a class of drugs known as nucleoside analogue reverse ... Entecavir - Medpedia


Up-to-date HIV and AIDS and Hepatitis treatment and care information Entecavir (Baraclude)


Learn about the prescription medication Baraclude (Entecavir), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Baraclude (Entecavir) Drug Information: Uses, Side Effects, Drug ...


A comprehensive site for hepatitis B symptom and treatment information at Baraclude.com. BARACLUDE (entecavir)


All about Entecavir Tablets. View complete and up to date Entecavir information - part of the Drugs.com trusted medication database. Entecavir Tablets Facts and Comparisons at Drugs.com


Physician reviewed entecavir patient information - includes entecavir description, dosage and directions. entecavir medical facts from Drugs.com


Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations. Entecavir: MedlinePlus Drug Information


Entecavir Brand names: Baraclude™ Drug Forms: Entecavir tablets (below) Entecavir oral solution Entecavir Oral solution Entecavir Oral tablet Entecavir: Information from Answers.com


Entecavir (pronounced /ɛnˈtɛkəvɪər/) is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude . Entecavir is a ... Entecavir - Wikipedia, the free encyclopedia





Featured Reviews

Reviews Norethindrone and Ethinyl Estradiol Tablets

Ovcon Drug Description OVCON®50 (norethindrone and ethinyl estradiol) Tablets, USP Patients should be counseled that this product does not protect against HIV-infection (AIDS) and other sexually transmitted diseases. DRUG DESCRIPTION OVCON&...
Read More  |  Review This
Reviews Entex Pse

Entex Pse Drug Description DRUG DESCRIPTION What are the possible side effects of guaifenesin and pseudoephedrine? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing;...
Read More  |  Review This
Reviews Anti-Inhibitor Coagulant Complex, Vapor Heated

Feiba Vh Drug Description FEIBA VH Anti-Inhibitor Coagulant Complex Vapor Heated DRUG DESCRIPTION What are the possible side effects of anti-inhibitor coagulant complex (Autoplex T, Feiba VH)? Anti-inhibitor coagulant complex...
Read More  |  Review This
Reviews Feraheme

Feraheme Drug Description Feraheme™ (ferumoxytol) Injection For Intravenous (IV) use DRUG DESCRIPTION What are the possible side effects of ferumoxytol (Feraheme)? Get emergency medical help if you have any of these signs...
Read More  |  Review This
Reviews Valtrex

Valtrex Drug Description VALTREX (valacyclovir hydrochloride) Caplets DRUG DESCRIPTION What are the possible side effects of valacyclovir (Valtrex)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....